While the World Health Organization has put the death rate from novel coronavirus, COVID-19, at 3.4%,1 a study in Nature Medicine put it much lower, at 1.4%.2 The fact is, with many cases going unreported and untested, mild and asymptomatic cases may not be included in official COVID-19 death rate figures, which could skew the… Read More »
FDA Approves Durysta (bimatoprost implant) to Lower Intraocular Pressure In Open-Angle Glaucoma or Ocular Hypertension Patients Print this page DUBLIN, March 5, 2020 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global pharmaceutical company with more than 70 years of heritage in eye care, today announced that the U.S. Food and Drug Administration (FDA) has… Read More »
Health Tech Jan 30, 2020• BY JESSICA DAMASSA, WTF HEALTH Livongo CEO, Zane Burke, has been a busy guy since the company’s IPO late last year. The applied health signals company has seen triple-digit (148%) growth and a robust expansion of the weight management and behavioral health platforms they’ve been building to support the ‘whole… Read More »
If your blood pressure is elevated, it’s certainly in your best interest to do what you can to bring it down to the normal range. That will lower your risk of having a heart attack or stroke, as well as prevent you from having your doctor prescribe drugs that can cause dizziness, headaches, fatigue, and… Read More »
High blood pressure is a deadly condition that affects more than one in four adults in the UK. The condition, which is also known as hypertension, could be caused by eating an unhealthy diet, or by not doing enough exercise. Diagnosing the condition early is crucial as it puts extra stress on your blood vessels… Read More »
A new study conducted in Japan found that the need to urinate in the night, called nocturia, may be linked to hypertension and high salt intake. Frequently going to the toilet at night may be a sign of high blood pressure, according to a new study. Nocturia is a condition in which people wake up… Read More »
FDA Approves Rocklatan (netarsudil and latanoprost ophthalmic solution) for the Reduction of Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension Print this page DURHAM, N.C.–(BUSINESS WIRE)–Mar. 12, 2019– Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie or the Company), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients… Read More »